AI predicts opioid relapse risk? new study tests Compl-AI model

NCT ID NCT07456930

Not yet recruiting Knowledge-focused Sponsor: Tools4Patient Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a tool called Compl-AI can predict which adults with opioid use disorder will stop their medication early. Researchers will observe 295 people receiving standard care and track their treatment attendance and adherence. The goal is to see if the model works in real-world settings, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify patients at risk of stopping their medication early, allowing for more personalized support.
What could go wrong: This is an observational study, not a treatment trial. The model may not be accurate in real-world settings, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

SOAP MAT, LLC - Central

San Diego, California, 92115, United States
SOAP MAT, LLC - Vista

Vista, California, 92083, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.